PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL)
CUSIP: 74019P207
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.000005 par value per share
- Shares outstanding
- 25,804,443
- Total 13F shares
- 3,786,321
- Share change
- -72,925
- Total reported value
- $18,062,451
- Price per share
- $4.77
- Number of holders
- 47
- Value change
- +$340,769
- Number of buys
- 15
- Number of sells
- 21
Quarterly Holders Quick Answers
What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74019P207:
Top shareholders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NOVARTIS PHARMA AG |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
12,407,440
|
$4,590,753 | — | 15 Jun 2022 | |
| Lynx1 Capital Management LP |
13F
|
Company |
3%
|
766,051
|
$2,918,654 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.6%
|
673,332
|
$2,565,395 | — | 31 Dec 2024 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
3.7%
|
406,250
|
$2,165,312 | $0 | 31 Mar 2025 | |
| Weinstein Benjamin |
13D/G
|
— |
5.2%
|
395,489
|
$2,107,956 | $0 | 18 Mar 2025 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
2.1%
|
536,376
|
$2,043,593 | — | 31 Dec 2024 | |
| Derek Jantz |
3/4/5
|
Chief Scientific Officer, Director |
—
mixed-class rows
|
4,079,565
mixed-class rows
|
$1,509,439 | — | 07 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
302,168
|
$1,151,260 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
278,222
|
$1,060,025 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.96%
|
248,620
|
$946,000 | — | 31 Dec 2024 | |
| Matthew R. Kane |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
2,026,513
mixed-class rows
|
$749,324 | — | 07 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.6%
|
153,675
|
$585,502 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.43%
|
109,798
|
$418,330 | — | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.39%
|
100,000
|
$381,000 | — | 31 Dec 2024 | |
| Moloney Securities Asset Management, LLC |
13F
|
Company |
0.34%
|
87,799
|
$334,514 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
68,615
|
$261,423 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
64,541
|
$245,934 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.21%
|
55,475
|
$211,360 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.21%
|
55,122
|
$210,014 | — | 31 Dec 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.18%
|
46,929
|
$178,799 | — | 31 Dec 2024 | |
| Samuel C. Wadsworth |
3/4/5
|
Director |
—
mixed-class rows
|
14,028
mixed-class rows
|
$161,277 | — | 04 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.16%
|
42,303
|
$161,000 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
38,364
|
$146,166 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
37,076
|
$141,260 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.11%
|
28,478
|
$108,500 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
27,537
|
$104,916 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
22,042
|
$83,980 | — | 31 Dec 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
0.08%
|
21,185
|
$80,715 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.07%
|
17,706
|
$67,460 | — | 31 Dec 2024 | |
| Samalin Investment Counsel, LLC |
13F
|
Company |
0.06%
|
15,545
|
$59,226 | — | 31 Dec 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.06%
|
15,534
|
$59,185 | — | 31 Dec 2024 | |
| Alan List |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
5,469
mixed-class rows
|
$56,440 | — | 01 May 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.05%
|
12,693
|
$48,000 | — | 31 Dec 2024 | |
| David S. Thomson |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
130,768
mixed-class rows
|
$41,260 | — | 23 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
7,774
|
$29,619 | — | 31 Dec 2024 | |
| Allworth Financial LP |
13F
|
Company |
0.02%
|
4,769
|
$23,702 | — | 31 Dec 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
0.02%
|
4,675
|
$17,812 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
4,308
|
$16,414 | — | 31 Dec 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.02%
|
4,000
|
$15,240 | — | 31 Dec 2024 | |
| Shane Barton |
3/4/5
|
VP & Corporate Controller |
—
mixed-class rows
|
33,562
mixed-class rows
|
$12,418 | — | 07 Jun 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
2,870
|
$10,935 | — | 31 Dec 2024 | |
| Fayaz Khazi |
3/4/5
|
CEO of Elo Life Systems |
—
mixed-class rows
|
65,239
mixed-class rows
|
$8,880 | — | 07 Jun 2021 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
1,600
|
$6,096 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,272
|
$4,845 | — | 31 Dec 2024 | |
| CWM, LLC |
13F
|
Company |
0%
|
1,005
|
$4,000 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
700
|
$2,667 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
445
|
$1,695 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
275
|
$1,047 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
152
|
$579 | — | 31 Dec 2024 | |
| SouthState Bank Corp |
13F
|
Company |
0%
|
95
|
$362 | — | 31 Dec 2024 |
Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) as of Q1 2025
As of 31 Mar 2025,
PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,786,321 shares.
The largest 10 holders included
Lynx1 Capital Management LP, Aquilo Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, Balyasny Asset Management L.P., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
51
Q1 2025 holders
47
Holder diff
-4
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.